|

SH009 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Nanjing Sanhome Pharmaceutical, Co., Ltd.1

Indications

  • Liver Disease1
  • Breast Cancer (Locally Advanced or Metastatic)1
  • Liver Cancer (Locally Advanced or Metastatic)1
  • Solid Tumor Malignancies1
  • Lung Cancer (NSCLC)1

Other1 trial

A Study of SH009 Injection in Patients With Advanced Solid Tumors.
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.